Microsatellite instability: a review of what the oncologist should know

The patients with high microsatellite instability (MSI-H)/mismatch repair deficient (dMMR) tumors recently have been reported that can benefit from immunotherapy, and MSI can be used as a genetic instability o...

Source: Cancer Cell International - January 13, 2020 Category: Cancer & Oncology Authors: Kai Li, Haiqing Luo, Lianfang Huang, Hui Luo and Xiao Zhu Tags: Review Source Type: research